AI in Pathology Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Scanners); By Neural Network; By Application; By End User; By Region; Segment Forecast, 2023- 2032

AI in Pathology Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Scanners); By Neural Network; By Application; By End User; By Region; Segment Forecast, 2023- 2032

The global AI in pathology market size is expected to reach USD 89.71 million by 2032, according to a new study by Polaris Market Research. The report “AI in pathology Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Scanners); By Neural Network; By Application; By End User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Initially, pathologists are used to examine pathology slides using microscopes. Visual observation and subjective interpretation have become ineffective in preventing intra- and interobserver disagreement. This facilitated the use of artificial intelligence in pathology, as automated approaches will improve the speed and accuracy of results, primarily through digital imaging. A recent study published in PubMed Central in 2022 evaluated the application of AI in pathology, along with trends and challenges.

The rising use of AI in computer applications is gaining traction among pathologists. The evolution of artificial intelligence, along with deep learning, is enabling image-based diagnosis with a background in digital pathology. Furthermore, the use of artificial intelligence by pathologists will save time and reduce errors, driving its use primarily in laboratories with more cases in the coming years.

The growing adoption of digital pathology laboratories at the global level is driving the use of artificial intelligence in the various tasks in pathology. A study published in 2023 focused on reviewing the digitalization of pathology labs. It revealed the benefits of digitalization, including lower reading time for cases and the need for second opinions. Digital pathology makes the diagnosis process faster and more efficient as it uses machine learning and artificial intelligence for the identification of diseases, symptoms, and ailments. This will enable scientists and doctors to choose the best treatment options, resulting in better patient outcomes.

As researchers come forward to check the reliability of artificial intelligence in pathology, there will be a rise in awareness about it among doctors, which may increase the adoption rate in the next few years.

AI in Pathology Market Report Highlights

The software segment is anticipated to witness the highest growth in the coming years due to advanced algorithms and improved diagnostics.

Conventional neural network segment accounted for the largest market share owing to the application of AI in image analysis.

The drug discovery segment is projected to experience a larger revenue share due to its ability to provide personalized medication.

Hospitals and reference laboratory segments are expected to witness significant growth owing to the prevalence of a higher caseload related to pathology.

Asia Pacific is projected to register the largest growth rate in the study period owing to the growing healthcare AI market.

The global players include 4D Path, Aiforia Technologies, Aiosyn, Akoya Biosciences, deepPath, Deep Bio, Hologic, Ibex Medical Analytics & Indica Labs.

Polaris Market Research has segmented the AI in pathology market report based on component, neural network, application, end user and region:

AI in Pathology, Component Outlook (Revenue - USD Million, 2019 - 2032)

Software

Scanners

AI in Pathology, Neural Network Outlook (Revenue - USD Million, 2019 - 2032)

Generative adversarial networks (GANS)

Convolutional neural networks (CNNs)

Recurrent neural networks (RNNs)

Others

AI in Pathology, Application Outlook (Revenue - USD Million, 2019 - 2032)

Drug Discovery

Disease Diagnosis & Prognosis

Clinical Workflow

Training & Education

AI in Pathology, End User Outlook (Revenue - USD Million, 2019 - 2032)

Pharmaceutical & Biotechnology Companies

Hospitals & Reference Laboratories

Academic & Research Institutes

AI in Pathology, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa